B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ALDH1A1

MOLECULAR TARGET

aldehyde dehydrogenase 1 family member A1

UniProt: P00352NCBI Gene: 2165 compounds

ALDH1A1 (aldehyde dehydrogenase 1 family member A1) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ALDH1A1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1napabucasin3.4330
2thiram2.4811
3bispiperidinylthiocarbonyldisulfide2.208
4Disulfiram0.691
5Perphenazine0.691

About ALDH1A1 as a Drug Target

ALDH1A1 (aldehyde dehydrogenase 1 family member A1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented ALDH1A1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ALDH1A1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.